Warning: session_start(): open(/var/cpanel/php/sessions/ea-php80/sess_3dab3879cdbbd583678508c6f721a20c, O_RDWR) failed: No space left on device (28) in /home/thealthcre/public_html/precedence/classes/cls-connection.php on line 9

Warning: session_start(): Failed to read session data: files (path: /var/cpanel/php/sessions/ea-php80) in /home/thealthcre/public_html/precedence/classes/cls-connection.php on line 9
U.S. Point-of-Care Infectious Disease Testing Market to Grow at 9.34% CAGR till 2034
Towards Healthcare
U.S. Point-of-Care Infectious Disease Testing Market to Grow at 9.34% CAGR til...

U.S. Point-of-Care Infectious Disease Testing Market Analysis 2025

According to market projections, the U.S. point-of-care infectious disease testing market, valued at USD 2.1 billion in 2024, is anticipated to reach USD 5.01 billion by 2034, growing at a CAGR of 9.34% over the next decade. The expanding growth of point-of-care testing for infectious diseases in the U.S. is driven by improved patient outcomes, increased healthcare efficiency, and reduced costs. The U.S. led the market in 2024, driven by value-based care and the expansion of alternative care settings.

Content

  • Insight Code: 6224
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

Talk to us
FAQ's

The U.S. point-of-care infectious disease testing market is worth USD 2.3 billion in 2025, and by 2034, it is forecasted to hit USD 5.01 billion, registering a CAGR of 9.34% over the decade.

The U.S. point-of-care infectious disease testing market includes 5 segments such as test technology/modality, pathogen/indication, format/product type, end-user/setting, and sample type.

Key trends include decentralization of testing, technological advancements, personalized medicine, etc.

NIH, NIBIB, CLIA, FDA, CMS.
Any Questions